Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10449
Title: | Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by Gastrins. | Austin Authors: | He, Hong ;Yim, Mildred;Liu, Kevin H;Cody, Stephen C;Shulkes, Arthur;Baldwin, Graham S | Affiliation: | Department of Surgery, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia 3084, Australia | Issue Date: | 11-Sep-2007 | Publication information: | Cellular Signalling 2007; 20(1): 83-93 | Abstract: | Gastrins, including amidated gastrin (Gamide) and glycine-extended gastrin (Ggly), are known to accelerate the growth of gastric and colorectal cancer cells by stimulation of proliferation and inhibition of apoptosis. Gamide controls apoptosis by regulation of proteins of the Bcl-2 family and by regulation of the activation of caspases. However the interactions between Ggly and proteins of the Bcl-2 family and caspases are not known. Since in other systems G proteins of the Rho family inhibit apoptosis via interaction with proteins of the Bcl-2 family, leading to changes in caspase activities, we have compared the role of Rho family G proteins in regulation of Bcl-2-like (Bad/Bax/Bcl-xl) protein expression and caspase 3 activation by Ggly and Gamide. The effects of the specific inhibitors C3 (for Rho) and Y-27632 (for ROCK), and of dominant negative mutants of Rac, Cdc42 and PAK, were investigated in the gastric epithelial cell line IMGE-5. Apoptosis was induced by serum starvation and confirmed by annexin V staining and caspase 3 activation. Ggly inhibits caspase 3 activation via a Bcl-2-like protein-mediated pathway which requires activation of both Rho/ROCK and Rac/Cdc42/PAK. Gamide inhibits caspase 3 activation via redundant Bcl-2-like protein-mediated pathways which involve alternative activation of Rac/Cdc42/PAK and Rho/ROCK. Gamide and Ggly differentially activate members of Rho family G proteins which in turn regulate different proteins of the Bcl-2 family leading to changes in caspase 3 activity. The findings offer potential targets for blocking the growth-stimulating effects of these gastrins. | Gov't Doc #: | 17936584 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/10449 | DOI: | 10.1016/j.cellsig.2007.08.018 | Journal: | Cellular signalling | URL: | https://pubmed.ncbi.nlm.nih.gov/17936584 | Type: | Journal Article | Subjects: | Amides.pharmacology Animals Apoptosis.drug effects Caspase 3.metabolism Cell Line Enzyme Inhibitors.pharmacology Epithelial Cells.metabolism Gastric Mucosa.cytology.metabolism Gastrins.physiology Mice Mice, Transgenic Proto-Oncogene Proteins c-akt.metabolism Proto-Oncogene Proteins c-bcl-2.metabolism Pyridines.pharmacology Signal Transduction.physiology bcl-2-Associated X Protein.metabolism bcl-X Protein.metabolism cdc42 GTP-Binding Protein.metabolism p21-Activated Kinases.metabolism rho GTP-Binding Proteins.metabolism rho-Associated Kinases.metabolism |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.